Angene Chemical
Draw
|
Currency :
Home Products

AG003U6M

65-45-2 | 2-Hydroxybenzamide

Chemical structure of 2-Hydroxybenzamide, CAS 65-45-2
AG003U6M
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 65-45-2
Catalog Number AG003U6M(AGN-PC-0JK758)
Chemical Name 2-Hydroxybenzamide
EC Number 200-609-3
IUPAC Name 2-hydroxybenzamide
InChI InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)
InChI Key SKZKKFZAGNVIMN-UHFFFAOYSA-N
MDL Number MFCD00007978
Molecular Formula C7H7NO2
Molecular Weight 137.1360
SMILES OC1=CC=CC=C1C(N)=O
UNII EM8BM710ZC
Synonyms
salicylamide, salicylamide sodium, salicylamide sulfate, salicylamide, 3H-labeled, salicylamide, calcium (2:1) salt, salicylamide, monosodium salt, salicylamide, 2-Hydroxybenzamide, 65-45-2, o-Hydroxybenzamide, Benzamide, 2-hydroxy-, Salicylic acid amide, 2-Carbamoylphenol, Salamide, Flarpirina, Morsarinas, Algamon, Algiamida, Allevin, Amidosal, Andasol, Dolomide, Dropsprin, Eggosalil, Novecyl, Panithal, Raspberin, Salamid, Saliamid, Saliamin, Salicim, Salipur, Salizell, Salymid, Serramida, Urtosal, Acket, Anamid, Oramid, Salrin, 2-Carboxamidophenol, Afko-Sal, Amid-Sal, Benzamide, o-hydroxy-, Salicilamida, Salicilamide, Salicylamidum, Salizell (VAN), Benesal (VAN), Salicilamide [DCIT], Salicilamide [Italian], Amid kyseliny salicylove, UNII-EM8BM710ZC, NSC 3115, Salicylamidum [INN-Latin], OHB, Salicilamida [INN-Spanish], MFCD00007978, H.P. 34, SR 4326, CCRIS 6045, HSDB 227, Salicylamide, 99%, Amid kyseliny salicylove [Czech], Benzoic acid, 2-hydroxy-, amide, EINECS 200-609-3, BRN 0742439, EM8BM710ZC, CHEMBL27577, AI3-03454, MLS000069486, CHEBI:32114, SKZKKFZAGNVIMN-UHFFFAOYSA-N, NCGC00091414-02, SMR000046394, DSSTox_CID_1726, DSSTox_RID_76295, DSSTox_GSID_21726, CAS-65-45-2, Salicylamid, Samid, Salicylamide [INN:BAN:JAN], hydroxy benzamide, Saliclamide,(S), dihydroxybenzalamine, 2-oxidanylbenzamide, Salicylamide [USP:INN:BAN:JAN], Salicylamide (TN), 2-Hydroxy-benzamide, PubChem10992, Spectrum_000946, ACMC-209nqv, AC1L1JPI, Opera_ID_1684, Spectrum2_001312, Spectrum3_000564, Spectrum4_000499, Spectrum5_001032, WLN: ZVR BQ, EC 200-609-3, AC1Q4Z8X, NCIOpen2_001127, Oprea1_069894, SCHEMBL21646, BSPBio_001948, KBioGR_001017, KBioSS_001426, 4-10-00-00169 (Beilstein Handbook Reference), KSC353S5B, DivK1c_000858, SPECTRUM1500532, Salicylamide (JAN/USP/INN), SPBio_001403, ZINC2055, DTXSID3021726, CTK2F3950, HMS502K20, KBio1_000858, KBio2_001426, KBio2_003994, KBio2_006562, KBio3_001448, NSC3115, NINDS_000858, HMS1920P14, HMS2092G15, HMS2232E07, Pharmakon1600-01500532, component of Tolagesic (Salt/Mix), HY-B0811, Hydrochlorothiazide Related Compound, KS-00000H1J, NSC-3115, Tox21_111129, Tox21_201944, Tox21_302801, ANW-35045, BBL016007, BDBM50056900, CCG-39250, NSC757318, SBB058584, STK301812, AKOS000120983, Tox21_111129_1, CS-7630, DB08797, LS-1556, MCULE-5482995635, NSC-757318, RP20335, RTR-022279, TRA0035157, IDI1_000858, NCGC00091414-01, NCGC00091414-03, NCGC00091414-04, NCGC00091414-05, NCGC00091414-07, NCGC00256376-01, NCGC00259493-01, AJ-08127, AK-81394, AN-23746, BR-81394, CJ-00076, DS-16216, Salicylamide, puriss., >=99.0% (T), SC-46863, SBI-0051509.P003, AB1004776, ST2410041, TR-022279, EU-0000058, FT-0659360, S0006, ST45061688, D01811, M-6078, 91096-EP2380872A1, AB00052089_12, A835120, AH-034/32461056, SR-01000721923, BENZOIC ACID,2-HYDROXY,AMIDE SALICYLAMIDE, I01-5217, J-509663, SR-01000721923-2, BRD-K81130846-001-02-6, BRD-K81130846-001-12-5, Z68590124, Salicylamide, United States Pharmacopeia (USP) Reference Standard, 2-HYDROXYBENZAMIDE (SEE ALSO:N-HYDROXYBENZAMIDE (CAS 495-18-1)), InChI=1/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10, Salicylamide, Pharmaceutical Secondary Standard; Certified Reference Material, Liquiprin, Cetamide, Benesal, Cymidon, Cidal, salicylamid-, Cymidon (VAN), Mixture Name, salicylamide sulfate, Rhinex D-Lay Tablets, component of Tolagesic, o-Hydroxybenzoesaureamid, C7H7NO2, salicylamide, 3H-labeled, SALICYLAMIDE SODIUM, Salicylamide, monosodium salt, Salicylamide [BAN:INN:JAN], Benzamide, 2-hydroxy- (9CI), CID5147, Salicylamide, 98% - 1KG 1kg, C7-H7-N-O2, Rhinex D-Lay Tablets (Salt/Mix), salicylamide, calcium (2:1) salt, ACN-001681, CS-O-07764, Salicylamide 99% pure confirming to USP 500gm, C031060, 2,4-Cyclohexadien-1-one, 6-(aminohydroxymethylene)- (9CI), 287492-04-0,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited